Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment

NCT00352885 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Depression

Interventions

DRUG: Escitalopram
DRUG: Placebo
DRUG: IL-2

Sponsor

Emory University

Collaborators

[object Object]